SIRPA and acute lymphoblastic leukemia: Additionally, the anti-CD47 antibody and anti-SIRPα antibody both increased phagocytosis of ALL cells in vitro, suggesting that blockade of the CD47/SIRPα signaling enhanced phagocytosis (123).